Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia in rats

International Journal of Developmental Neuroscience

Volumn 33, Issue 1, 2014, Pages 88-97

  Gutierres, Jessié M ^a   Carvalho, Fabiano B ^a   Schetinger, Maria Rosa C ^a   Agostinho, Paula ^b   Marisco, Patricia C ^a   Vieira, Juliano M ^a   Rosa, Michele M ^a   Bohnert, Crystiani ^a   Rubin, Maribel A ^a   Morsch, Vera M ^a   Spanevello, Roselia ^c   Mazzanti, Cinthia M ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Acetylcholinesterase; Anthocyanins; Anxiety like behavior; Memory; Scopolamine

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTHOCYANIN; CHOLINERGIC RECEPTOR; NITRATE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BEHAVIORAL SCIENCE; BRAIN CORTEX; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SCOPOLAMINE-INDUCED AMNESIA; TRANQUILIZING ACTIVITY;

ACETYLCHOLINESTERASE; ANTHOCYANINS; ANXIETY-LIKE BEHAVIOR; MEMORY; SCOPOLAMINE;

ACETYLCHOLINESTERASE; AMNESIA; ANIMALS; ANTHOCYANINS; AVOIDANCE LEARNING; BRAIN; CHOLINERGIC ANTAGONISTS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; LACTATE DEHYDROGENASES; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; SCOPOLAMINE HYDROBROMIDE; SODIUM-POTASSIUM-EXCHANGING ATPASE; SYNAPTOSOMES; TIME FACTORS;

EID: 84892473219     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.12.006     Document Type: Article

References (127)

1. Ali E.H., Arafa N.M. Comparative protective action of curcumin, memantine and diclofenac against scopolamine-induced memory dysfunction. Fitoterapia 2011, 82:601-608.
2. Anagnostaras S.G., Josselyn S.A., Frankland P.W., Silva A.J. Computer-assisted behavioral assessment of Pavlovian fear conditioning in mice. Learn. Mem. 2000, 7:58-72.
3. Andres-Lacueva C., Shukitt-Hale B., Galli R.L., Jauregui O., Lamuela-Raventos R.M., Joseph J.A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr. Neurosci. 2005, 8:111-120.
4. Appleyard M.E. Non-cholinergic functions of acetylcholinesterase. Biochem. Soc. Trans. 1994, 22:749-755.
5. Archibald J.T., White T.D. Rapid reversal of internal Na+ and K+ contents of synaptosomes by ouabain. Nature 1974, 252:595-596.
6. Ashmore L.J., Hrizo S.L., Paul S.M., Van Voorhies W.A., Beitel G.J., Palladino M.J. Novel mutations affecting the Na, K ATPase alpha model complex neurological diseases and implicate the sodium pump in increased longevity. Hum. Genet. 2009, 126:431-447.
7. Barros D., Amaral O.B., Izquierdo I., Geracitano L., do Carmo Bassols Raseira M., Henriques A.T., Ramirez M.R. Behavioral and genoprotective effects of Vaccinium berries intake in mice. Pharmacol. Biochem. Behav. 2006, 84:229-234.
8. Barzilai N., Atzmon G., Derby C.A., Bauman J.M., Lipton R.B. A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology 2006, 67:2170-2175.
9. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 2001, 125:141-149.
10. Berlese D.B., Sauzem P.D., Carati M.C., Guerra G.P., Stiegemeier J.A., Mello C.F., Rubin M.A. Time-dependent modulation of inhibitory avoidance memory by spermidine in rats. Neurobiol. Learn. Mem. 2005, 83:48-53.
11. Berrocal M., Marcos D., Sepulveda M.R., Perez M., Avila J., Mata A.M. Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease. FASEB J. 2009, 23:1826-1834.
12. Blin J., Piercey M.F., Giuffra M.E., Mouradian M.M., Chase T.N. Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography. J. Neurol. Sci. 1994, 123:44-51.
13. Blitzer R.D., Gil O., Landau E.M. Cholinergic stimulation enhances long-term potentiation in the CA1 region of rat hippocampus. Neurosci. Lett. 1990, 119:207-210.
14. Blokland A. Acetylcholine: a neurotransmitter for learning and memory?. Brain Res. Brain Res. Rev. 1995, 21:285-300.
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
16. Bymaster F.P., Carter P.A., Peters S.C., Zhang W., Ward J.S., Mitch C.H., Calligaro D.O., Whitesitt C.A., DeLapp N., Shannon H.E., Rimvall K., Jeppesen L., Sheardown M.J., Fink-Jensen A., Sauerberg P. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects. Brain Res. 1998, 795:179-190.
17. Bymaster F.P., Shannon H.E., Rasmussen K., Delapp N.W., Mitch C.H., Ward J.S., Calligaro D.O., Ludvigsen T.S., Sheardown M.J., Olesen P.H., Swedberg M.D., Sauerberg P., Fink-Jensen A. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane. Eur. J. Pharmacol. 1998, 356:109-119.
18. Candore G., Balistreri C.R., Listi F., Grimaldi M.P., Vasto S., Colonna-Romano G., Franceschi C., Lio D., Caselli G., Caruso C. Immunogenetics, gender, and longevity. Ann. N. Y. Acad. Sci. 2006, 1089:516-537.
19. Carvalho F.B., Mello C.F., Marisco P.C., Tonello R., Girardi B.A., Ferreira J., Oliveira M.S., Rubin M.A. Spermidine decreases Na(+),K(+)-ATPase activity through NMDA receptor and protein kinase G activation in the hippocampus of rats. Eur. J. Pharmacol. 2012, 684:79-86.
20. Chacon M.A., Reyes A.E., Inestrosa N.C. Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J. Neurochem. 2003, 87:195-204.
21. Choi D.Y., Lee Y.J., Lee S.Y., Lee Y.M., Lee H.H., Choi I.S., Oh K.W., Han S.B., Nam S.Y., Hong J.T. Attenuation of scopolamine-induced cognitive dysfunction by obovatol. Arch. Pharm. Res. 2012, 35:1279-1286.
22. Christensen H., Maltby N., Jorm A.F., Creasey H., Broe G.A. Cholinergic 'blockade' as a model of the cognitive deficits in Alzheimer's disease. Brain 1992, 115(Pt 6):1681-1699.
23. Clarke R.J., Fan X. Pumping ions. Clin. Exp. Pharmacol. Physiol. 2011, 38:726-733.
24. Del Rio D., Borges G., Crozier A. Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br. J. Nutr. 2010, 104(Suppl. 3):S67-S90.
25. DiPolo R., Beauge L. Regulation of Na-Ca exchange. An overview. Ann. N. Y. Acad. Sci. 1991, 639:100-111.
26. Dominguez L.J., Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J. Cardiometab. Syndr. 2007, 2:183-189.
27. dos Reis E.A., de Oliveira L.S., Lamers M.L., Netto C.A., Wyse A.T. Arginine administration inhibits hippocampal Na(+),K(+)-ATPase activity and impairs retention of an inhibitory avoidance task in rats. Brain Res. 2002, 951:151-157.
28. Duffy K.B., Spangler E.L., Devan B.D., Guo Z., Bowker J.L., Janas A.M., Hagepanos A., Minor R.K., DeCabo R., Mouton P.R., Shukitt-Hale B., Joseph J.A., Ingram D.K. A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats. Neurobiol. Aging 2008, 29:1680-1689.
29. Edirisinghe I., Banaszewski K., Cappozzo J., McCarthy D., Burton-Freeman B.M. Effect of black currant anthocyanins on the activation of endothelial nitric oxide synthase (eNOS) in vitro in human endothelial cells. J. Agric. Food Chem. 2011, 59:8616-8624.
30. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
31. El-Sherbiny D.A., Khalifa A.E., Attia A.S., Eldenshary Eel D. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol. Biochem. Behav. 2003, 76:525-533.
32. Erecinska M., Silver I.A. Tissue oxygen tension and brain sensitivity to hypoxia. Respir. Physiol. 2001, 128:263-276.
33. Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J. Bioenerg. Biomembr. 2009, 41:425-431.
34. Fiske C.H., Subbarow Y. The nature of the "inorganic phosphate" in voluntary muscle. Science 1927, 65:401-403.
35. Frank J., Kamal-Eldin A., Lundh T., Maatta K., Torronen R., Vessby B. Effects of dietary anthocyanins on tocopherols and lipids in rats. J. Agric. Food Chem. 2002, 50:7226-7230.
36. Frussa-Filho R., Barbosa-Junior H., Silva R.H., Da Cunha C., Mello C.F. Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments. Psychopharmacology (Berl.) 1999, 147:168-173.
37. Fujisawa H., Kajikawa K., Ohi Y., Hashimoto Y., Yoshida H. Movement of radioactive calcium in brain slices and influences on it of protoveratrine, ouabain, potassium chloride and cocaine. Jpn. J. Pharmacol. 1965, 15:327-334.
38. Geering K. Na,K-ATPase. Curr. Opin. Nephrol. Hypertens. 1997, 6:434-439.
39. Giacomello M., De Mario A., Scarlatti C., Primerano S., Carafoli E. Plasma membrane calcium ATPases and related disorders. Int. J. Biochem. Cell. Biol. 2013, 45:753-762.
40. Glushchenko T.S., Izvarina N.L. Na+,K(+)-ATPase activity in neurons and glial cells of the olfactory cortex of the rat brain during the development of long-term potentiation. Neurosci. Behav. Physiol. 1997, 27:49-52.
41. Grisar T., Guillaume D., Delgado-Escueta A.V. Contribution of Na+,K(+)-ATPase to focal epilepsy: a brief review. Epilepsy Res. 1992, 12:141-149.
42. Gron G., Brandenburg I., Wunderlich A.P., Riepe M.W. Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis. Neurobiol. Aging 2006, 27:78-87.
43. Gutierres J.M., Carvalho F.B., Rosa M.M., Schmatz R., Rodrigues M., Vieira J.M., Mazzanti C.M., Morsch V.M., Rubin M.A., Schetinger M.R.C., Spanevello R.M. Protective effect of α-Tocopherol on memory deficits and Na+,K+-ATPase and acetylcholinesterase activities in rats with diet-induced hypercholesterolemia. Biomed. Aging Pathol. 2012, 2:73-80.
44. Gutierres J.M., Carvalho F.B., Schetinger M.R., Rodrigues M.V., Schmatz R., Pimentel V.C., Vieira J.M., Rosa M.M., Marisco P., Ribeiro D.A., Leal C., Rubin M.A., Mazzanti C.M., Spanevello R. Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats. Life Sci. 2012, 91:1221-1228.
45. Gutierres J.M., Kaizer R.R., Schmatz R., Mazzanti C.M., Vieira J.M., Rodrigues M.V., Jaques J., Carvalho F., Zanini D., Morsch V.M., Schetinger M.R., Spanevello R.M. α-Tocopherol regulates ectonucleotidase activities in synaptosomes from rats fed a high-fat diet. Cell Biochem. Funct. 2012, 30:286-292.
46. Gutierres J.M., Carvalho F.B., Schetinger M.R., Marisco P., Agostinho P., Rodrigues M., Rubin M.A., Schmatz R., da Silva C.R., de P.C.G., Morsch V.M., Mazzanti C.M., Bogo M., Bonan C.D., Spanevello R. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type. Life Sci. 2013, pii:S0024-3205(13)00713-3. 10.1016/j.lfs.2013.11.014.
47. Hattori N., Kitagawa K., Higashida T., Yagyu K., Shimohama S., Wataya T., Perry G., Smith M.A., Inagaki C. CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains. Neurosci. Lett. 1998, 254:141-144.
48. Hauptmann S., Scherping I., Drose S., Brandt U., Schulz K.L., Jendrach M., Leuner K., Eckert A., Muller W.E. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol. Aging 2009, 30:1574-1586.
49. Honer W.G., Prohovnik I., Smith G., Lucas L.R. Scopolamine reduces frontal cortex perfusion. J. Cereb. Blood Flow Metab. 1988, 8:635-641.
50. Hut R.A., Van der Zee E.A. The cholinergic system, circadian rhythmicity, and time memory. Behav. Brain Res. 2011, 221:466-480.
51. Ibach B., Haen E. Acetylcholinesterase inhibition in Alzheimer's disease. Curr. Pharm. Des. 2004, 10:231-251.
52. Izquierdo I. Mechanism of action of scopolamine as an amnestic. Trends Pharmacol. Sci. 1989, 10:175-177.
53. Jeong E.J., Lee K.Y., Kim S.H., Sung S.H., Kim Y.C. Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. Eur. J. Pharmacol. 2008, 588:78-84.
54. Jorgensen P.L., Hakansson K.O., Karlish S.J. Structure and mechanism of Na,K-ATPase: functional sites and their interactions. Annu. Rev. Physiol. 2003, 65:817-849.
55. Kahkonen M.P., Heinonen M. Antioxidant activity of anthocyanins and their aglycons. J. Agric. Food Chem. 2003, 51:628-633.
56. Kahkonen M.P., Hopia A.I., Heinonen M. Berry phenolics and their antioxidant activity. J. Agric. Food Chem. 2001, 49:4076-4082.
57. Kaplan J.H. Biochemistry of Na,K-ATPase. Annu. Rev. Biochem. 2002, 71:511-535.
58. Kasa P., Rakonczay Z., Gulya K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 1997, 52:511-535.
59. Kim H.G., Ju M.S., Shim J.S., Kim M.C., Lee S.H., Huh Y., Kim S.Y., Oh M.S. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models. Br. J. Nutr. 2010, 104:8-16.
60. Kirvela O.A., Kanto J.H., Raty H.M., Iisalo E. Anticholinergic drugs: effects on oxygen consumption and energy expenditure. Anesth. Analg. 1994, 78:995-999.
61. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci. Biobehav. Rev. 2010, 34:1307-1350.
62. Kodavanti P.R. Measurement of calcium buffering by intracellular organelles in brain. Methods Mol. Med. 1999, 22:171-176.
63. Kopelman M.D., Corn T.H. Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain 1988, 111(Pt 5):1079-1110.
64. Krikorian R., Eliassen J.C., Boespflug E.L., Nash T.A., Shidler M.D. Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr. Neurosci. 2010, 13:116-122.
65. Krikorian R., Shidler M.D., Nash T.A., Kalt W., Vinqvist-Tymchuk M.R., Shukitt-Hale B., Joseph J.A. Blueberry supplementation improves memory in older adults. J. Agric. Food Chem. 2010, 58:3996-4000.
66. Krikorian R., Boespflug E.L., Fleck D.E., Stein A.L., Wightman J.D., Shidler M.D., Sadat-Hossieny S. Concord grape juice supplementation and neurocognitive function in human aging. J. Agric. Food Chem. 2012, 60:5736-5742. 10.1021/jf300277g.
67. Lacor P.N. Advances on the understanding of the origins of synaptic pathology in AD. Curr. Genomics 2007, 8:486-508.
68. Lane R.M., Potkin S.G., Enz A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol. 2006, 9:101-124.
69. Lees G.J., Lehmann A., Sandberg M., Hamberger A. The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor, in the rat hippocampus. Neurosci. Lett. 1990, 120:159-162.
70. Lingrel J.B., Williams M.T., Vorhees C.V., Moseley A.E. Na,K-ATPase and the role of alpha isoforms in behavior. J. Bioenerg. Biomembr. 2007, 39:385-389.
71. Maggi S., Noale M., Zambon A., Limongi F., Romanato G., Crepaldi G. Validity of the ATP III diagnostic criteria for the metabolic syndrome in an elderly Italian Caucasian population: the Italian Longitudinal Study on Aging. Atherosclerosis 2008, 197:877-882.
72. Malatova Z., Nicak A., Marsala J. Acetylcholinesterase activity and its molecular forms in selected regions of the dog's nervous system. Physiol. Bohemoslov. 1980, 29:415-422.
73. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79:727-747.
74. Marisco P.C., Carvalho F.B., Rosa M.M., Girardi B.A., Gutierres J.M., Jaques J.A., Salla A.P., Pimentel V.C., Schetinger M.R., Leal D.B., Mello C.F., Rubin M.A. Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5'-nucleotidase and adenosine deaminase activities. Neurochem. Res. 2013, 38:1704-1714.
75. Mata A.M., Sepulveda M.R. Plasma membrane Ca-ATPases in the nervous system during development and ageing. World J. Biol. Chem. 2010, 1:229-234.
76. Mata A.M., Berrocal M., Sepulveda M.R. Impairment of the activity of the plasma membrane Ca(2)(+)-ATPase in Alzheimer's disease. Biochem. Soc. Trans. 2011, 39:819-822.
77. Matsumoto H., Inaba H., Kishi M., Tominaga S., Hirayama M., Tsuda T. Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J. Agric. Food Chem. 2001, 49:1546-1551.
78. Mazzanti C.M., Spanevello R.M., Pereira L.B., Goncalves J.F., Kaizer R., Correa M., Ahmed M., Mazzanti A., Festugatto R., Graca D.L., Morsch V.M., Schetinger M.R. Acetylcholinesterase activity in rats experimentally demyelinated with ethidium bromide and treated with interferon beta. Neurochem. Res. 2006, 31:1027-1034.
79. McGhie T.K., Ainge G.D., Barnett L.E., Cooney J.M., Jensen D.J. Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats. J. Agric. Food Chem. 2003, 51:4539-4548.
80. Mehta P.D. Amyloid beta protein as a marker or risk factor of Alzheimer's disease. Curr. Alzheimer Res. 2007, 4:359-363.
81. Messer W.S., Bohnett M., Stibbe J. Evidence for a preferential involvement of M1 muscarinic receptors in representational memory. Neurosci. Lett. 1990, 116:184-189.
82. Michaelis E.K., Michaelis M.L., Chang H.H., Kitos T.E. High affinity Ca2+-stimulated Mg2+-dependent ATPase in rat brain synaptosomes, synaptic membranes, and microsomes. J. Biol. Chem. 1983, 258:6101-6108.
83. Min J., Yu S.W., Baek S.H., Nair K.M., Bae O.N., Bhatt A., Kassab M., Nair M.G., Majid A. Neuroprotective effect of cyanidin-3-O-glucoside anthocyanin in mice with focal cerebral ischemia. Neurosci. Lett. 2011, 500:157-161.
84. Miranda K.M., Espey M.G., Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001, 5:62-71.
85. Miyazawa T., Nakagawa K., Kudo M., Muraishi K., Someya K. Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. J. Agric. Food Chem. 1999, 47:1083-1091.
86. Moseley A.E., Williams M.T., Schaefer T.L., Bohanan C.S., Neumann J.C., Behbehani M.M., Vorhees C.V., Lingrel J.B. Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J. Neurosci. 2007, 27:616-626.
87. Mudnic I., Budimir D., Modun D., Gunjaca G., Generalic I., Skroza D., Katalinic V., Ljubenkov I., Boban M. Antioxidant and vasodilatory effects of blackberry and grape wines. J. Med. Food 2012, 15(3):315-321. (Epub Nov 14, 2011). 10.1089/jmf.2011.0129.
88. Musial A., Bajda M., Malawska B. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr. Med. Chem. 2007, 14:2654-2679.
89. Nagy A., Delgado-Escueta A.V. Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient material (Percoll). J. Neurochem. 1984, 43:1114-1123.
90. Nishizuka T., Fujita Y., Sato Y., Nakano A., Kakino A., Ohshima S., Kanda T., Yoshimoto R., Sawamura T. Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox. Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci. 2011, 87:104-113.
91. Paleari L., Grozio A., Cesario A., Russo P. The cholinergic system and cancer. Semin. Cancer Biol. 2008, 18:211-217.
92. Palop J.J., Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
93. Parsons J.T., Sun D.A., DeLorenzo R.J., Churn S.B. Neuronal-specific endoplasmic reticulum Mg(2+)/Ca(2+) ATPase Ca(2+) sequestration in mixed primary hippocampal culture homogenates. Anal. Biochem. 2004, 330:130-139.
94. Pavlov K.V., Sokolov V.S. Electrogenic ion transport by Na+,K+-ATPase. Membr. Cell Biol. 2000, 13:745-788.
95. Ramirez M.R., Izquierdo I., do Carmo Bassols Raseira M., Zuanazzi J.A., Barros D., Henriques A.T. Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol. Res. 2005, 52:457-462.
96. Rang Oh S., Jin Kim S., Hyun Kim D., Hoon Ryu J., Ahn E.M., Wook Jung J. Angelica keiskei ameliorates scopolamine-induced memory impairments in mice. Biol. Pharm. Bull. 2013, 36:82-88. (Epub Nov 5, 2012).
97. Ray C.A., Blin J., Chase T.N., Piercey M.F. Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat. Neuropharmacology 1992, 31:1193-1199.
98. Rohn T.T., Hinds T.R., Vincenzi F.F. Ion transport ATPases as targets for free radical damage. Protection by an aminosteroid of the Ca2+ pump ATPase and Na+/K+ pump ATPase of human red blood cell membranes. Biochem. Pharmacol. 1993, 46:525-534.
99. Rose A.M., Valdes R. Understanding the sodium pump and its relevance to disease. Clin. Chem. 1994, 40:1674-1685.
100. Rubin M.A., Albach C.A., Berlese D.B., Bonacorso H.G., Bittencourt S.R., Queiroz C.M., Maixner A.E., Mello C.F. Anxiolytic-like effects of 4-phenyl-2-trichloromethyl-3H-1, 5-benzodiazepine hydrogen sulfate in mice. Braz. J. Med. Biol. Res. 2000, 33:1069-1073.
101. Rubin M.A., Boemo R.L., Jurach A., Rojas D.B., Zanolla G.R., Obregon A.D., Souza D.O., Mello C.F. Intrahippocampal spermidine administration improves inhibitory avoidance performance in rats. Behav. Pharmacol. 2000, 11:57-61.
102. Saija A., Princi P., D'Amico N., De Pasquale R., Costa G. Effect of Vaccinium myrtillus anthocyanins on triiodothyronine transport into brain in the rat. Pharmacol. Res. 1990, 22(Suppl. 3):59-60.
103. Sakurai T., Kato T., Mori K., Takano E., Watabe S., Nabeshima T. Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: an in vivo microdialysis study. Neurosci. Lett. 1998, 246:69-72.
104. Sansoni P., Vescovini R., Fagnoni F., Biasini C., Zanni F., Zanlari L., Telera A., Lucchini G., Passeri G., Monti D., Franceschi C., Passeri M. The immune system in extreme longevity. Exp. Gerontol. 2008, 43:61-65.
105. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130:2073S-2085S.
106. Scarpini E., Cogiamanian F. Alzheimer's disease: from molecular pathogenesis to innovative therapies. Expert Rev. Neurother. 2003, 3:619-630.
107. Scarpini E., Scheltens P., Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol. 2003, 2:539-547.
108. Scuri R., Lombardo P., Cataldo E., Ristori C., Brunelli M. Inhibition of Na+/K+ ATPase potentiates synaptic transmission in tactile sensory neurons of the leech. Eur. J. Neurosci. 2007, 25:159-167.
109. Shen Z.X. Brain cholinesterases: I. The clinico-histopathological and biochemical basis of Alzheimer's disease. Med. Hypotheses 2004, 63:285-297.
110. Shih P.H., Chan Y.C., Liao J.W., Wang M.F., Yen G.C. Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer's disease. J. Nutr. Biochem. 2010, 21:598-605.
111. Skou J.C., Esmann M. The Na,K-ATPase. J. Bioenerg. Biomembr. 1992, 24:249-261.
112. Southam E., Thomas P.K., King R.H., Goss-Sampson M.A., Muller D.P. Experimental vitamin E deficiency in rats. Morphological and functional evidence of abnormal axonal transport secondary to free radical damage. Brain 1991, 114(Pt 2):915-936.
113. Stone W.S., Walser B., Gold S.D., Gold P.E. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists. Behav. Neurosci. 1991, 105:264-271.
114. Therien A.G., Blostein R. Mechanisms of sodium pump regulation. Am. J. Physiol. Cell Physiol. 2000, 279:C541-C566.
115. Trevisan G., Maldaner G., Velloso N.A., Sant'Anna Gda S., Ilha V., Velho Gewehr Cde C., Rubin M.A., Morel A.F., Ferreira J. Antinociceptive effects of 14-membered cyclopeptide alkaloids. J. Nat. Prod. 2009, 72:608-612.
116. Varadinova M.G., Docheva-Drenska D.I., Boyadjieva N.I. Effects of anthocyanins on learning and memory of ovariectomized rats. Menopause 2009, 16:345-349.
117. Veitch N.C., Grayer R.J. Flavonoids and their glycosides, including anthocyanins. Nat. Prod. Rep. 2008, 25:555-611.
118. Verkhratsky A., Rodriguez J.J., Parpura V. Calcium signalling in astroglia. Mol. Cell. Endocrinol. 2012, 353:45-56.
119. Wang L.S., Stoner G.D. Anthocyanins and their role in cancer prevention. Cancer Lett. 2008, 269:281-290.
120. Wesnes K.A., Simpson P.M., White L., Pinker S., Jertz G., Murphy M., Siegfried K. Cholinesterase inhibition in the scopolamine model of dementia. Ann. N. Y. Acad. Sci. 1991, 640:268-271.
121. Williams C.A., Grayer R.J. Anthocyanins and other flavonoids. Nat. Prod. Rep. 2004, 21:539-573.
122. Xiao A.Y., Wei L., Xia S., Rothman S., Yu S.P. Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J. Neurosci. 2002, 22:1350-1362.
123. Yamaguchi M. Role of regucalcin in brain calcium signaling: involvement in aging. Integr. Biol. (Camb.) 2012, 4:825-837.
124. Yoshida K., Mori M., Kondo T. Blue flower color development by anthocyanins: from chemical structure to cell physiology. Nat. Prod. Rep. 2009, 26:884-915.
125. Youdim K.A., Dobbie M.S., Kuhnle G., Proteggente A.R., Abbott N.J., Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J. Neurochem. 2003, 85:180-192.
126. Zaidi A. Plasma membrane Ca-ATPases: targets of oxidative stress in brain aging and neurodegeneration. World J. Biol. Chem. 2010, 1:271-280.
127. Zakut H., Matzkel A., Schejter E., Avni A., Soreq H. Polymorphism of acetylcholinesterase in discrete regions of the developing human fetal brain. J. Neurochem. 1985, 45:382-389.